Explore 3 Stock Ideas & Industry Insights Download Free Report

News

PRO DEX INC Reports $77.55M Fiscal 2026 Net Sales

Medical device products and related services accounted for 98% of revenue. Non-recurring engineeringRevenuerepresented 2% of fiscal 2026 revenue, compared with 1% in fiscal 2025.

Vinay Lochav | 04 September 2026

ProtoKinetix Posts $393,650 Loss, Seeks More Research Funding

For 2025, ProtoKinetix, Inc. (OTC: PKTX) recorded recurring operating losses of $393,650. The research and development-stage biotechnology company said it needs to increase funding for research activities and will likely require additional funds. ProtoKinetix reported no operating revenues and said its ability to advance …

Vinay Lochav | 04 September 2026

REX American Resources Reports $53.4M Six-Month Net Income (NYSE: REX)

REX AMERICAN RESOURCES Corp (NYSE: REX) reported approximately $53.4 million in net income attributable to common shareholders for the first six months, compared with approximately $15.8 million in the prior-year period. The ethanol producer operates through one reportable segment covering ethanol and by-products. REX …

Vinay Lochav | 04 September 2026

MATRIX SERVICE CO (NASDAQ: MTRX) Revenue Rises 14% as Fiscal 2027 Revenue Recognition Is Expected

MATRIX SERVICE CO (NASDAQ: MTRX) reported fiscal 2026 revenue of $873.632 million, up $104.346 million, or 14%, from the previous year. Net loss narrowed to $2.580 million from $29.462 million. Approximately 79% of total backlog recorded at June 30, 2026 is expected to be …

Vinay Lochav | 04 September 2026

Medtronic (NYSE: MDT) Revenue Reaches $9.76B as Net Income Climbs to $1.47B

Medtronic plc (NYSE: MDT) generated $9,756 million ($9.756 billion) in net sales for the three months ended July 31, 2026, compared with $8,578 million in the comparable period. Net income attributable to Medtronic reached $1,470 million, up from $1,040 million. Diluted earnings per share …

Vinay Lochav | 04 September 2026

Latigo Biotherapeutics Reports $25.8M Quarterly Net Loss (NASDAQ: LTGO)

Latigo Biotherapeutics, Inc. (NASDAQ: LTGO) recorded a net loss of $25,797,000 ($25.797 million) for the quarter ended June 30, 2026.Research and Developmentcosts declined as direct development costs fell, while personnel-related and other research expenses increased.

Vinay Lochav | 04 September 2026

LSI Industries Reports $689.397M Revenue, 20% Growth, $22.579M Profit (NASDAQ: LYTS)

LSI Industries Inc. (NASDAQ: LYTS) generated $689.397 million inRevenuefor the year ended June 30, 2026, up 20% from $573.377 million. Net income was $22.579 million, whileBasic Earnings Per Sharewere $0.69 andDiluted Earnings per Sharewere $0.67. TotalOperating Incomereached $38.403 million.

Vinay Lochav | 04 September 2026

Lululemon Athletica Inc. Cuts Revenue 4% to $2.4B (NASDAQ: LULU)

Lululemon athletica inc. (NASDAQ: LULU) reported second-quarter net revenue of $2.4 billion, down 4% from the comparable period, while comparable sales decreased 9%. On a constant dollar basis, revenue declined 5% and comparable sales fell 10%.Diluted Earnings per Sharewere $2.92, compared with $3.10 in …

Vinay Lochav | 04 September 2026

Lululemon Reports $2.42B Second-Quarter Revenue (NASDAQ: LULU)

Lululemon athletica inc. (NASDAQ: LULU) recorded $2,415,631,000 in net revenue for the second quarter of fiscal 2026, covering the quarter ended August 2, 2026. The period also forms part of the first two quarters of fiscal 2026, during which net revenue totaled $4,887,234,000. Geographic …

Vinay Lochav | 04 September 2026

Mama’s Creations Raises Q2 Revenue 55% to $54.6M (NASDAQ: MAMA)

Mama’s Creations, Inc. (NASDAQ: MAMA) reported second-quarter fiscal 2027 revenue of $54.6 million, up 55.0% year-over-year for the quarter ended July 31, 2026. Cash and cash equivalents reached $138.6 million after the July common stock offering.

Vinay Lochav | 04 September 2026
Support

Hi! How can we help you today?

Loading…